Testimonies from the Trenches: Innovations in Clinical Practice. Buprenorphine in Residential Treatment Settings. This is a 30 minute didactic presentation with (.5 CME). This presentation is a description of Buprenorphine as used in an inpatient residential treatment center. It will guide the practitioner through detox, inpatient care and the eventual discharge and post-discharge planning. This webinar is free to AOAAM members. Non-members at $25. Consider membership!

1. Understand the Options of Medicated Assisted Treatment (MAT) for Opioid Use Disorders
2. To create a framework for guiding a patient to the appropriate MAT
3. Detox and Induction of Buprenorphine
4. Post Discharge referrals

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

1. Complete the required course materials.
2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

• A comfort level on when and how to begin Buprenorphine in detox. (competence, performance)
• The process of making the best decision for an individual patient's MAT (competence, performance and patient outcomes)
• A look at the many factors that are involved in this process (competence)

CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.